Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer

by longitudeadmin | Dec 17, 2015 | Portfolio News

Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer

Collegium Announces Publication of Nasal Human Abuse Potential Study in American Academy of Pain Medicine

by longitudeadmin | Dec 16, 2015 | Portfolio News

Practice Fusion Expands Executive Team with Hiring of New Chief Operating Officer; Promotes New Senior VP of Product Management

by longitudeadmin | Dec 16, 2015 | Portfolio News

Corcept Therapeutics Announces Initial Efficacy Results in Phase 1/2 Trial of Mifepristone in Combination With Eribulin for the Treatment of Patients With Metastatic Triple-Negative Breast Cancer

by longitudeadmin | Dec 14, 2015 | Portfolio News

Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer

by longitudeadmin | Dec 14, 2015 | Portfolio News

« Older Entries

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2025 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer